Archimedes Tech SPAC Partners II

ATII · NASDAQ

$9.81+$2.64 (+36.82%)TodayMarket closed · Oct 21, 7:59 PM ET

Prev close $7.17

Latest news

NewsSep 22, 8:49 AM ET
Archimedes Tech SPAC Partners II Merger Partner Forge Nano Signs Joint Development Agreement With Nanexa To Develop Scalable Pharmaceutical Manufacturing Capabilities For The PharmaShell Drug Delivery Platform
Press releaseSep 22, 8:47 AM ETGlobe Newswire
Forge Nano and Nanexa Enter Joint Development Agreement to Advance Manufacturing for ALD-Coated PharmaShell® Long-Acting Injectable Medicines
Press releaseMay 7, 8:30 AM ETGlobe Newswire
Forge Nano Achieves ISO 9001 Certification as Demand Grows for U.S.-Made Battery Supply Chains
Press releaseApr 21, 10:00 AM ETGlobe Newswire
Forge Nano, U.S. Advanced Manufacturing Leader for AI-Era Chips and Defense Batteries, to List on NASDAQ through Merger with Archimedes Tech SPAC Partners II Co.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Archimedes Tech SPAC Partners II Merger Partner Forge Nano Signs Joint Development Agreement With Nanexa To Develop Scalable Pharmaceutical Manufacturing Capabilities For The PharmaShell Drug Delivery Platform

Forge Nano and Nanexa Enter Joint Development Agreement to Advance Manufacturing for ALD-Coated PharmaShell® Long-Acting Injectable Medicines

Forge Nano Achieves ISO 9001 Certification as Demand Grows for U.S.-Made Battery Supply Chains

Forge Nano, U.S. Advanced Manufacturing Leader for AI-Era Chips and Defense Batteries, to List on NASDAQ through Merger with Archimedes Tech SPAC Partners II Co.